Causal Relationships Between Circulating Inflammatory Proteins and Obstructive Sleep Apnea: A Bidirectional Mendelian Randomization Study
Zhengjie Chen,Jinjie Zeng,Xiang Pei,Jingjing Zhao,Fang Zhao,Guoxin Zhang,Kexin Liang,Jiarong Li,Xiaoyun Zhao
DOI: https://doi.org/10.2147/nss.s458637
2024-06-14
Nature and Science of Sleep
Abstract:Zhengjie Chen, 1, 2, &ast Jinjie Zeng, 3, &ast Xiang Pei, 1, 2 Jingjing Zhao, 1, 2 Fang Zhao, 1, 2 Guoxin Zhang, 1, 2 Kexin Liang, 1, 2 Jiarong Li, 2 Xiaoyun Zhao 1, 2, 4, 5 1 Clinical School of Thoracic, Tianjin Medical University, Tianjin, People's Republic of China; 2 Department of Respiratory & Critical Care Medicine, Tianjin Chest Hospital, Tianjin, People's Republic of China; 3 Department of Respiratory, The Third Central Hospital of Tianjin, Tianjin, People's Republic of China; 4 Department of Respiratory & Critical Care Medicine, Chest Hospital of Tianjin University, Tianjin, People's Republic of China; 5 DeepinBreath Union Laboratory, Tianjin Chest Hospital, Tianjin, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiaoyun Zhao, Department of Respiratory & Critical Care Medicine, Tianjin Chest Hospital, No. 261 Taierzhuang South Road, Jinnan District, Tianjin, People's Republic of China, Email Purpose: Clinical studies have demonstrated the intricate association between the onset and progression of obstructive sleep apnea (OSA) and the activation of the inflammatory cascade reaction. This study delves into investigating the causal links between 91 circulating inflammatory proteins (CIPs) and OSA through the application of Mendelian randomization (MR) techniques. Methods: Utilizing genetic data on OSA sourced from the Finnish Biobank (FinnGen) Genome-wide Association Studies (GWAS) of the European population, alongside summary-level GWAS data of CIPs from 14,824 European participants, we conducted a bidirectional MR study. Results: This study suggests that several factors may be associated with the risk of OSA. IL-17C (odds ratio (OR) = 1.090, p = 0.0311), CCL25 (OR = 1.079, p = 0.0493), FGF-5 (OR = 1.090, p = 0.0003), CD5 (OR = 1.055, p = 0.0477), and TNFSF14 (OR = 1.092, p = 0.0008) may positively correlate with OSA risk. Conversely, IL-20RA (OR = 0.877, p = 0.0107), CCL19 (OR = 0.933, p = 0.0237), MIP-1 alpha (OR = 0.906, p = 0.0042), Flt3L (OR = 0.941, p = 0.0019), CST5 (OR = 0.957, p = 0.0320), OPG (OR = 0.850, p = 0.0001), and TRAIL (OR = 0.956, p = 0.0063) may reduce the risk of OSA. Additionally, elevated levels of IL-10RA (OR = 1.153, p = 0.0478) were observed as a consequence of OSA. Conversely, OSA may potentially lead to decreased levels of CCL28 (OR = 0.875, p = 0.0317), DNER (OR = 0.874, p = 0.0324), FGF-21 (OR = 0.846, p = 0.0344), and CSF-1 (OR = 0.842, p = 0.0396). Conclusion: Through this bidirectional MR study, we have identified 12 upstream regulatory proteins and 5 downstream effect proteins that are linked to OSA. These findings hold promise in providing potential therapeutic targets for the inflammatory mechanisms underlying OSA. Keywords: Mendelian randomization, bidirectional, obstructive sleep apnea, circulating inflammatory proteins The fundamental attributes of obstructive sleep apnea (OSA) encompass the recurrent obstruction of the upper airway during sleep, resulting in periodic hypoxemia, disturbances in sleep continuity, and increased respiratory exertion. Consequently, this sequence induces activation of the sympathetic nervous system, oxidative stress, and the emergence of systemic inflammatory responses. 1 Epidemiological research indicates that approximately 936 million adults aged 30 to 69 globally are afflicted with OSA. 2 With a prevalence of approximately 22% in males and 17% in females, OSA stands as a prevalent sleep breathing disorder in clinical contexts. 3 A comprehensive comprehension of the pathophysiological mechanisms governing OSA is imperative for effective clinical intervention. The systemic inflammatory cascade is thought to assume a crucial role in both the commencement and development of OSA. 4 Prior clinical investigations have explored the plasma concentrations of inflammatory markers in both OSA patients and controls, uncovering elevated levels of plasma high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and pentraxin-3 (PTX-3) in individuals with OSA. 5 Nonetheless, a separate study found no statistically significant differences in serum levels of IL-6 (p = 0.782) and TNF-α (p = 0.722) between OSA patients and the controls. Furthermore, continuous positive airway pressure (CPAP) treatment demonstrated no significant impact on IL-6 and TNF-α levels. 6 The Multicenter Obstructive Sleep Apnea Interventional Cardiovascular (MO -Abstract Truncated-
neurosciences,clinical neurology